Bioventix Plc Director Dealing
October 27 2022 - 2:00AM
UK Regulatory
TIDMBVXP
Bioventix plc
("Bioventix" or "the Company")
Director Dealing
Bioventix plc (BVXP), a UK company specialising in the development and
commercial supply of high-affinity monoclonal antibodies for applications in
clinical diagnostics, announces that it has been notified that Bruce Hiscock,
Chief Financial Officer of the Company, completed the following dealings in the
Company's ordinary shares of 5 pence in the Company ("Ordinary Shares"):
* the transfer, via sale and purchase, of 204 Ordinary Shares into his ISA.
Mr Hiscock sold 204 Ordinary Shares at a price of £33.41 from an account in
his own name and bought 204 Ordinary Shares at a price of £34.00 to be held
in his ISA; and
* the additional purchase of 276 Ordinary Shares at a price of £34.00 into
his ISA.
Following these transactions, Mr Hiscock's total beneficial interest in the
Company is now 700 Ordinary Shares, representing approximately 0.01 per cent.
of the Company's total issued share capital.
For further information please contact:
Bioventix plc Tel: 01252 728 001
Peter Harrison Chief Executive Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Simon Hicks/Abigail Corporate Finance
Kelly ECM
Alice Lane
1. Details of the person discharging managerial responsibilities / person
closely associated
a) Name Bruce Hiscock
2. Reason for the Notification
a) Position/status Chief Financial Officer
b) Initial notification/ Initial notification
Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Bioventix plc
b) LEI 213800225MHX7LZQY108
4. Details of the transaction(s): section to be repeated for (i) each type
of instrument; (ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
a) Description of the Ordinary Shares
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
b) Nature of the Sale of Ordinary Shares
transaction
c) Price(s) and volume(s) Volume(s) Prices (pence)
204 3,341
d) Aggregated information: Sale of 204 Ordinary Shares at a price of 3,341p
·Aggregated volume per Ordinary Share
·Price
e) Date of the transaction 26 October 2022
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
1. Details of the person discharging managerial responsibilities / person
closely associated
a) Name Bruce Hiscock
2. Reason for the Notification
a) Position/status Chief Financial Officer
b) Initial notification/ Initial notification
Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Bioventix plc
b) LEI 213800225MHX7LZQY108
4. Details of the transaction(s): section to be repeated for (i) each type
of instrument; (ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
a) Description of the Ordinary Shares
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
b) Nature of the Purchase of Ordinary Shares
transaction
c) Price(s) and volume(s) Volume(s) Prices (pence)
480 3,400
d) Aggregated information: Purchase of 480 Ordinary Shares at a price of
·Aggregated volume 3,400p per Ordinary Share
·Price
e) Date of the transaction 26 October 2022
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
END
(END) Dow Jones Newswires
October 27, 2022 02:00 ET (06:00 GMT)
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Oct 2024 to Nov 2024
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Nov 2023 to Nov 2024
